These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30503868)

  • 1. The Relationship Between Increased Ratio of Visceral-to-Subcutaneous Fat Area and Renal Outcome in Chinese Adults With Type 2 Diabetes and Diabetic Kidney Disease.
    Wang Y; Chen F; Wang J; Wang T; Zhang J; Han Q; Wu Y; Zhang R; Liu F
    Can J Diabetes; 2019 Aug; 43(6):415-420. PubMed ID: 30503868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy.
    Hanai K; Babazono T; Nyumura I; Toya K; Ohta M; Bouchi R; Suzuki K; Inoue A; Iwamoto Y
    Clin Exp Nephrol; 2010 Apr; 14(2):132-6. PubMed ID: 20091203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent association between the visceral adiposity index and microalbuminuria in patients with newly diagnosed type 2 diabetes.
    Wen J; Yuan H
    Diabetes Metab Res Rev; 2020 Jan; 36(1):e3198. PubMed ID: 31228226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study.
    Wan EYF; Yu EYT; Chin WY; Lau CST; Mok AHY; Wang Y; Wong ICK; Chan EWY; Lam CLK
    Sci Rep; 2021 Apr; 11(1):8047. PubMed ID: 33850209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes.
    Bouchi R; Takeuchi T; Akihisa M; Ohara N; Nakano Y; Nishitani R; Murakami M; Fukuda T; Fujita M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2015 Oct; 14():136. PubMed ID: 26445876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of visceral-to-subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes.
    Fukuda T; Bouchi R; Takeuchi T; Nakano Y; Murakami M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    J Diabetes Investig; 2018 Mar; 9(2):396-402. PubMed ID: 28686352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma.
    Kaneko G; Miyajima A; Yuge K; Yazawa S; Mizuno R; Kikuchi E; Jinzaki M; Oya M
    Jpn J Clin Oncol; 2015 Feb; 45(2):210-6. PubMed ID: 25420691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does body fat mass define survival in patients starting peritoneal dialysis?
    Choi SJ; Kim EJ; Park MY; Kim JK; Hwang SD
    Perit Dial Int; 2014 Jun; 34(4):376-82. PubMed ID: 23378474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus.
    Iwasaki T; Nakajima A; Yoneda M; Terauchi Y
    Endocr J; 2006 Jun; 53(3):345-56. PubMed ID: 16714840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes.
    Han J; Kim SH; Suh YJ; Lim HA; Shin H; Cho SG; Kim CW; Lee SY; Lee DH; Hong S; Kim YS; Nam MS
    J Korean Med Sci; 2016 Jun; 31(6):924-31. PubMed ID: 27247502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus.
    Kim SR; Yoo JH; Song HC; Lee SS; Yoo SJ; Kim YD; Lim YS; Kim HW; Yang CW; Kim YS; Choi EJ; Kim YK
    Nephrol Dial Transplant; 2011 Nov; 26(11):3550-5. PubMed ID: 21030458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients.
    Taniguchi A; Nakai Y; Sakai M; Yoshii S; Hamanaka D; Hatae Y; Kawata M; Yamanouchi K; Okumura T; Doi K; Tokuyama K; Nagasaka S; Fukushima M
    Metabolism; 2002 May; 51(5):544-8. PubMed ID: 11979383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher visceral fat area/subcutaneous fat area ratio measured by computed tomography is associated with recurrence and poor survival in patients with mid and low rectal cancers.
    Lee KH; Kang BK; Ahn BK
    Int J Colorectal Dis; 2018 Sep; 33(9):1303-1307. PubMed ID: 29713823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus.
    Suzuki D; Toyoda M; Kimura M; Miyauchi M; Yamamoto N; Sato H; Tanaka E; Kuriyama Y; Miyatake H; Abe M; Umezono T; Fukagawa M
    Intern Med; 2013; 52(10):1029-34. PubMed ID: 23676586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients.
    Kato A; Ishida J; Endo Y; Takita T; Furuhashi M; Maruyama Y; Odamaki M
    Nephrol Dial Transplant; 2011 Jun; 26(6):1967-76. PubMed ID: 20980356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?
    Bouchi R; Ohara N; Asakawa M; Nakano Y; Takeuchi T; Murakami M; Sasahara Y; Numasawa M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2016 Jan; 15():10. PubMed ID: 26790628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes.
    Chen X; Mao Y; Hu J; Han S; Gong L; Luo T; Yang S; Qing H; Wang Y; Du Z; Mei M; Zheng L; Lv X; Tang Y; Zhao Q; Zhou Y; He JC; Li Q; Wang Z
    Diabetes; 2021 Oct; 70(10):2322-2332. PubMed ID: 34593536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of visceral fat area in patients with chronic kidney disease.
    Manabe S; Kataoka H; Mochizuki T; Iwadoh K; Ushio Y; Kawachi K; Watanabe K; Watanabe S; Akihisa T; Makabe S; Sato M; Iwasa N; Yoshida R; Sawara Y; Hanafusa N; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2021 Jun; 25(6):608-620. PubMed ID: 33595731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.